Growth • Simulations Plus
SLP
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
15,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-10,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
3%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
0,4%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-2,9%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
2,7%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!